/PRNewswire/ The "Small Intestinal Bacterial Overgrowth Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis; Type, and.
E-Mail
Metabolic bone disease is a common complication of chronic kidney disease (CKD) and involves a broad spectrum of disorders of mineral metabolism that result in both skeletal and extra-skeletal consequences.
A new special issue of
Calcified Tissue International brings together a comprehensive series of state-of-the-art reviews which discuss key issues in CKD and mineral and bone disorders, known as CKD-MBD. Authored by a multidisciplinary group of leading international experts, the wide-ranging reviews aim to improve the understanding and management of CKD-MBD, and advance interdisciplinary knowledge.
Professors René Rizzoli and Stuart Ralston, Editors of
Calcified Tissue International, stated: We greatly thank the authors for their contributions and the guest editors Professors J. B Cannata-Andía, N. Carrillo-López, and A. Ferreira, for curating this excellent series of reviews. The special issue brings together multidisciplinary expertise and covers many key
Published: Apr 05, 2021
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE)
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its presence at the National Kidney Foundation’s 2021 Spring Clinical Meetings, which will take place virtually, April 6-10, 2021.
As a leader in non-invasive approaches for assessing the health of transplanted kidneys, CareDx will host
“Next Generation Care for Kidney Transplant Patients,” a 30-minute exhibitor showcase on April 6th from 11:00-11:30 a.m. Eastern Time.
Program details:
Innovations in Kidney Transplant Care, with Dr. Christopher Boshkos, Medical Director of Kidney Transplantation at CareDx